Free Trial

Verici Dx (VRCI) Competitors

Verici Dx logo
GBX 1.50 -0.13 (-7.69%)
As of 12:17 PM Eastern

VRCI vs. YGEN, ABDX, GDR, PRM, GENI, DMTR, LLAI, LLA, IDHC, and DXRX

Should you be buying Verici Dx stock or one of its competitors? The main competitors of Verici Dx include Yourgene Health (YGEN), Abingdon Health (ABDX), genedrive (GDR), Proteome Sciences (PRM), GENinCode (GENI), Deepmatter Group (DMTR), LungLife AI (LLAI), LLA.L,0P0001T9GN,0 (LLA), Integrated Diagnostics (IDHC), and Diaceutics (DXRX). These companies are all part of the "diagnostics & research" industry.

Verici Dx vs.

Yourgene Health (LON:YGEN) and Verici Dx (LON:VRCI) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, analyst recommendations, community ranking, dividends, media sentiment, institutional ownership, profitability, valuation and earnings.

Verici Dx has lower revenue, but higher earnings than Yourgene Health. Verici Dx is trading at a lower price-to-earnings ratio than Yourgene Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Yourgene Health£29.67M0.00-£8.17M-£0.01N/A
Verici Dx£5.91M0.77-£6.56M-£1.73-0.87

Yourgene Health has a net margin of -27.55% compared to Verici Dx's net margin of -110.99%. Yourgene Health's return on equity of -27.06% beat Verici Dx's return on equity.

Company Net Margins Return on Equity Return on Assets
Yourgene Health-27.55% -27.06% -6.71%
Verici Dx -110.99%-71.67%-26.14%

23.3% of Yourgene Health shares are owned by institutional investors. Comparatively, 51.9% of Verici Dx shares are owned by institutional investors. 64.4% of Yourgene Health shares are owned by company insiders. Comparatively, 17.1% of Verici Dx shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Yourgene Health received 17 more outperform votes than Verici Dx when rated by MarketBeat users.

CompanyUnderperformOutperform
Yourgene HealthOutperform Votes
17
53.13%
Underperform Votes
15
46.88%
Verici DxN/AN/A

Yourgene Health has a beta of 0.86, meaning that its share price is 14% less volatile than the S&P 500. Comparatively, Verici Dx has a beta of 1.59, meaning that its share price is 59% more volatile than the S&P 500.

In the previous week, Yourgene Health's average media sentiment score of 0.00 equaled Verici Dx'saverage media sentiment score.

Company Overall Sentiment
Yourgene Health Neutral
Verici Dx Neutral

Summary

Yourgene Health beats Verici Dx on 7 of the 11 factors compared between the two stocks.

Get Verici Dx News Delivered to You Automatically

Sign up to receive the latest news and ratings for VRCI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

VRCI vs. The Competition

MetricVerici DxDiagnostics & Research IndustryMedical SectorLON Exchange
Market Cap£4.55M£729.90M£5.47B£2.56B
Dividend YieldN/A5.44%5.11%4.97%
P/E Ratio-0.871.8522.51132.50
Price / Sales0.77447.32397.62227,865.53
Price / Cash1.3111.4238.1828.11
Price / Book0.342.686.734.54
Net Income-£6.56M£308.37B£3.22B£5.84B
7 Day Performance-14.29%-1.66%1.58%3.31%
1 Month Performance-49.49%-2.98%4.05%9.43%
1 Year Performance-80.00%-8.38%15.75%114.47%

Verici Dx Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VRCI
Verici Dx
N/AGBX 1.50
-7.7%
N/A-79.4%£4.55M£5.91M-0.8719Gap Down
YGEN
Yourgene Health
N/AN/AN/AN/A£16.43M£29.67M-51.50253
ABDX
Abingdon Health
N/AGBX 6
+4.3%
N/A-43.6%£11.62M£3.84M-14.5984Positive News
Gap Up
GDR
genedrive
N/AGBX 1.52
+2.7%
N/A-70.1%£8.63M£1.50M-0.4343
PRM
Proteome Sciences
N/AGBX 2.55
-10.4%
N/A-23.1%£7.51M£10.88B-1.84240Gap Down
GENI
GENinCode
N/AGBX 2.49
+1.5%
N/A-80.7%£4.41M£2.67M-0.732,300
DMTR
Deepmatter Group
N/AN/AN/AN/A£1.33M£1.04M-0.11N/AGap Down
LLAI
LungLife AI
N/AGBX 2.05
-8.8%
N/A-91.1%£680,000.00£33,871.03-0.1615Gap Down
High Trading Volume
LLA
LLA.L,0P0001T9GN,0
N/AN/AN/AN/A£0.00N/A-8.3315Gap Down
High Trading Volume
IDHC
Integrated Diagnostics
N/AGBX 0.36
+2.6%
N/A+16.7%£10.60B£23.29T13.386,692Gap Up
DXRX
Diaceutics
2.8587 of 5 stars
GBX 118
-0.4%
GBX 160
+35.6%
+21.2%£99.59M£26.08M-35.00151News Coverage

Related Companies and Tools


This page (LON:VRCI) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners